Malignant Focal Liver Lesions Other Than HCC Pablo R. Ros, MD, MPH, PhD Departments of Radiology and Pathology University Hospitals Cleveland Medical Center Case Western Reserve University Pablo.Ros@UHhospitals.org
Malignant Focal Liver Lesions Other than HCC HEPATOCELLULAR ORIGIN Fibrolamellar carcinoma (FLC) CHOLANGIOCELLULAR ORIGIN Cholangiocarcinoma (I-CAC) Cystadenocarcinoma
Malignant Focal Liver Lesions Other than HCC MESENCHYMAL ORIGIN Angiosarcoma Epithelioid Hemangioendothelioma Kaposi sarcoma Primary lymphoma METASTASIS
Malignant Focal Liver Lesions Unknown Case 56 yo man with jaundice and abdominal pain
T2 FS T1 FS arterial T1 FS delayed
What is the most likely diagnosis? A. Intrahepatic Cholangiocarcinoma B. Epithelioid Hemangioendothelioma C. Fibrolamellar carcinoma D. Metastasis E. Angiosarcoma
What is the most likely diagnosis? A. Intrahepatic Cholangiocarcinoma B. Epithelioid Hemangioendothelioma C. Fibrolamellar carcinoma D. Metastasis E. Ansgiosarcoma
Malignant Focal Liver Lesions Unknown Case 19 yo man with complex medical history, now with elevated liver function tests and palpable mid abdominal mass
T2 FS T1 FS T1 FS 2 min - Eovist T1 FS 20 min - Eovist
What is the most likely diagnosis? A. Intrahepatic Cholangiocarcinoma B. Epithelioid Hemangioendothelioma C. Fibrolamellar carcinoma D. Metastasis E. Cystadenocarcinoma
What is the most likely diagnosis? A. Intrahepatic Cholangiocarcinoma B. Epithelioid Hemangioendothelioma C. Fibrolamellar carcinoma D. Metastasis E. Cystadenocarcinoma
What is the key finding? A.Size B. Lobular contour C. Small calcifications D.Hypodense
What is the key CT finding? A.Size B. Lobular contour C. Small calcifications D.Hypodense
Malignant Focal Liver Lesions Unknown Case 61 yo woman Intermittent abdominal pain and distension RUQ ultrasound, followed by CT Second abdominal CT scan, 8 months after initial one
What is the most likely diagnosis? A. Intrahepatic Cholangiocarcinoma B. Epithelioid Hemangioendothelioma C. Fibrolamellar carcinoma D. Metastasis E. Angisarcoma
What is the most likely diagnosis? A. Intrahepatic Cholangiocarcinoma B. Epithelioid Hemangioendothelioma C. Fibrolamellar carcinoma D. Metastasis E. Angiosarcoma
Malignant Focal Liver Lesions Unknown Case 54 yo woman Abdominal pain Bloating Her two dogs died recently due to chronic arsenic intoxication
What is the most likely diagnosis? A. Intrahepatic Cholangiocarcinoma B. Epithelioid Hemangioendothelioma C. Fibrolamellar carcinoma D. Metastasis E. Angisarcoma
What is the most likely diagnosis? A. Intrahepatic Cholangiocarcinoma B. Epithelioid Hemangioendothelioma C. Fibrolamellar carcinoma D. Metastasis E. Angisarcoma
Malignant Focal Liver Lesions Unknown Case 55 yo woman with liver mass on ultrasound
What is the most likely diagnosis? A. Intrahepatic Cholangiocarcinoma B. Epithelioid Hemangioendothelioma C. Fibrolamellar carcinoma D. Metastasis E. Angiosarcoma
What is the most likely diagnosis? A. Intrahepatic Cholangiocarcinoma B. Epithelioid Hemangioendothelioma C. Fibrolamellar carcinoma D. Metastasis E. Cystadenocarcinoma
Metastasis 10 times more frequent than primary malignant liver neoplams Multiple If solitary, likely from Colon Adenocarcinoma HCC, 10 times more frequent than other primary liver tumors
Fibrolamellar Carcinoma - Malignant Hepatocytes - Lamellar fibrosis - Confluent centrally - AFP negative
Fibrolamellar Carcinoma - Poorer vascularity, Bile stained - Central scar, Radiating Septa - No vessels in scar - Calcification
Fibrolamellar Carcinoma
Fibrolamellar Carcinoma: Scar - Low signal in T2 - No enhancement - Calcification
Fibrolamellar Carcinoma - Heterogeneous - Poor vascularity - Ill defined scar
Fibrolamellar Carcinoma Heterogeneous No Calcifications No FDG activity
Fibrolamellar Carcinoma
Fibrolamellar Carcinoma Homogeneous, but Calcifications
Fibrolamellar Carcinoma
MALIGNANT HEPATIC NEOPLASMS CHOLANGIOCELLULAR ORIGIN Cholangiocarcinoma (I-CAC) Cystadenocarcinoma
Intrahepatic Cholangiocarcinoma (I-CAC) Microscopy Adenocarcinoma: mucin rich, no bile Abundant fibrous stroma Calcification
I-CAC - Large (5-20 cm), - Solid (Hemorrhage/necrosis rare) - Fibrous, scar, calcifications - Satellite nodules (20%) - Local extension, no tumor thrombus
I-CAC Pathogenesis/Associations Thorotrast Hepatolithiasis (5% - 20%) Clonorchis sinensis Sclerosing Cholangitis Caroli Disease Congenital Hepatic Fibrosis
I-CAC Hypodense, homogeneous, irregular borders Capsular Retraction Satellite nodules No Cirrhosis
I-CAC Biliary dilatation, segmental
I-CAC
I-CAC T1: Hypointense Early: Peripheral enhancement
I-CAC Late: central enhancement in scar
I-CAC Vascular encasement, no invasion Extrahepatic local extension
MALIGNANT HEPATIC NEOPLASMS MESENCHYMAL ORIGIN Angiosarcoma Epithelioid Hemangioendothelioma Kaposi sarcoma Primary lymphoma
Risk Factors: Thorotrast, Vinyl chloride, Arsenicals
Angiosarcoma Pathologic Findings Foci of malignant endothelial cells Along vascular spaces Thorotrast granules displaced peripherally
Angiosarcoma Pathologic Findings - Multinodular (70%) - Solitary - Thorotrast peripherally displaced reticulated surface fibrosis
Angiosarcoma - Thorotrast, liver, spleen, lymph nodes peripherally displaced
Angiosarcoma
Angiosarcoma
Angiosarcoma
Angiosarcoma
Epithelioid Hemangioendothelioma Slow, peripheral (subcapsular) growth Hypertrophy of uninvolved liver
Epithelioid Hemangioendothelioma
Epithelioid Hemangioendothelioma Nonspecific symptoms or asymptomatic (20%) Slow, peripheral (subcapsular) growth Hypertrophy of uninvolved liver
Epithelioid Hemangioendothelioma Peripheral, globular enhancement Intratumoral shunting Invasive
Regarding Primary Hepatic Lymphoma? A. The liver is commonly involved B. Its contour is ill defined C. It is typically Hodgkin Disease D. Typically has calcifications E. Solitary, multiple and diffuse forms
Regarding Primary Hepatic Lymphoma? A. The liver is commonly involved B. Its contour is ill defined C. It is typically Hodgkin Disease D. Typically has calcifications E. Solitary, multiple and diffuse forms
Lymphoma Primary lymphoma, extremely rare NHL, diffuse large cell type Immunocompromised (transplant, IDS, ) Solitary, Multiple, Diffuse Low attenuation, well defined MRI preferred for diffuse form
Lymphoma NHL, Hemosiderosis Multiple, well defined nodules Hypodense, No enhancement
Lymphoma Diffuse Geographic involvement Spleen deposit
Malignant Focal Liver Lesions Other than HCC HEPATOCELLULAR ORIGIN Fibrolamellar carcinoma (FLC) CHOLANGIOCELLULAR ORIGIN Cholangiocarcinoma (I-CAC) Cystadenocarcinoma
Malignant Focal Liver Lesions Other than HCC MESENCHYMAL ORIGIN Angiosarcoma Epithelioid Hemangioendothelioma Kaposi sarcoma Primary lymphoma METASTASIS
Malignant Focal Liver Lesions More than Metastasis and HCC Gamut of primary malignant neoplasms Different cellular lines and appearances Imaging: Benign vs. Malignant Primary vs. Secondary Resectable vs. Unresectable Imaging guided Biopsy Percutaneous therapy
Surgical vs. Nonsurgical Lesions Cyst Focal Fat Flow Phenomenon Abscess Hemangioma FNH Unresectable metastasis